Page results
-
Dr Alegre Abarrategui is a consultant in diagnostic neuropathology offering diagnostic services across neuropathology subspecialties, especially surgical neuropathology, neuromuscular neuropathology, and neurodegeneration.
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
A new scan could improve how millions of people with high blood pressure are treated, suggests a new study led by UCL and conducted at UCLH.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
This easy read page offers advice for patients on managing pain after an operation.
-
This page is for cancer patients receiving immunotherapy treatment.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
Court of Appeal has ruled in favour of the Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS).
-
Information for service users about the RESPOND service for refugees and asylum seekers.
File results
-
FOI/2022/0639 - Digital dictation, voice recognition, and medical transcription suppliers
-
FOI/2022/0642 - Staff musculoskeletal disorder sustained undertaking patient handling
-
FOI/2022/0645 - Maintenance of endoscopes and associated equipment
-
FOI/2022/0646 - Endoscopic Retrogade Cholangiopancreatography
-
FOI/2022/0652 - UCLH palliative care policy
-
FOI/2022/0656 - Reinforced autoclaved aerated concrete (RAAC)
-
FOI/2022/0660 - Prostate cancer
-
FOI/2022/0663 - Migraine treatment
-
FOI/2022/0665 - Formal patient/ family complaints
-
FOI/2022/0672 - Data Centre